Xoma | XOMA - Cash And Equivalent

Stock Price
25.81
Daily Change
1.41 5.78%
Monthly
-5.35%
Yearly
9.74%
Q1 Forecast
25.01

Xoma reported $143.9M in Cash and Equivalent for its fiscal quarter ending in June of 2024.





Cash And Equivalent Change Date
AbbVie USD 5.23B 400M Dec/2025
Agenus USD 3.46M 6.08M Sep/2025
Agios Pharmaceuticals USD 89.13M 3.58M Dec/2025
Ardelyx USD 42.72M 47.32M Sep/2025
aTyr Pharma USD 6.15M 11.07M Sep/2025
BioMarin Pharmaceutical USD 1.25B 36.29M Sep/2025
Celldex Therapeutics USD 36.04M 12.99M Sep/2025
Curis USD 10.14M 10.14M Jun/2025
Eli Lilly USD 7.27B 2.52B Dec/2025
Emergent BioSolutions USD 111.7M 23.9M Dec/2023
Incyte USD 3.58B 650.78M Dec/2025
MacroGenics USD 80.13M 50.56M Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
Pfizer USD 1.34B 295M Sep/2025
Prothena USD 330.84M 40.6M Sep/2025
Regeneron Pharmaceuticals USD 18.87B 16.36B Dec/2025
Xoma USD 143.9M 7.68M Jun/2024